US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
RSS Feeds

Biotechnology market research reports and industry analysis

1    3    5  6  7  8  9  10  
Analytical Instruments: United States
8/1/2014 | published by: Freedonia Focus Reports
... terms of laboratory instruments, process control instruments, electrical measuring equipment, and other instruments. To illustrate historical trends, total demand and shipments are provided in annual series from 2003 to 2013; the various segments are reported ...  |  read more...
USD 600
Proteomics, Global
8/12/2014 | published by: Plimsoll Publishing Ltd.
... includes a wealth of information on the financial trends over the past four years. latest Proteomics Global analysis is perfect for investors to: See the market leaders Identify companies heading for failure Seek out the ...  |  read more...
USD 1,425
Biomarkers in Amyotrophic Lateral Sclerosis
8/1/2014 | published by: CHI Insight Pharma Reports
... a Diagnostic Approach to Neurodegenerative Disorders, this report focuses on the ALS space featured in the parent report, highlighting several biomarker targets under investigation and the progress that has been made in the industry. With ...  |  read more...
USD 699
Covance Inc.: Competitive Benchmarking Report
8/1/2014 | published by: The Business Analysts' Group
... comparative analysis on these metrics, this Competitive Benchmarking Report has two USPs, which distinguishes this report from any other available competitive benchmarking report on this company: 1. Industry Analysis Section: This section covers an analytical ...  |  read more...
USD 1,799
Elan Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Elan and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Gilead Sciences Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... partnering is finding those companies that are potential partners for the development and commercialization of the next generation of therapies as developed by innovative biopharma R&D companies. A lot of resources are spent on finding ...  |  read more...
USD 995
Immunomedics Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... you require to better understand Immunomedics and its partnering interests and activities over the past seven years. On demand company reports are prepared upon purchase to ensure inclusion of the most up to date deal ...  |  read more...
USD 995
Sexually Transmitted Diseases Partnering 2009-2014
8/1/2014 | published by: Current Partnering
... in sexually transmitted diseases partnering deals •Top sexually transmitted diseases deals by value •Deals listed by company A-Z, industry sector, stage of development, technology type The Sexually Transmitted Diseases Partnering 2009-2014 provides understanding and access ...  |  read more...
USD 995
Biotechnology Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Big Biotech Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. The initial chapters of this report provide an orientation of 2013’s dealmaking ...  |  read more...
USD 1,495
Cell Therapy Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... healthcare companies during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals ...  |  read more...
USD 1,495
Genomics Deals and Alliances of 2013
8/1/2014 | published by: Current Partnering
... during 2013. Using these reports, dealmakers will effectively and efficiently gain insight into the partnering activities of the past year. The report series allows you to view all the partnering and alliances deals announced worldwide. ...  |  read more...
USD 1,495
Proteins in Oncology Drug Pipeline Update 2014
7/15/2014 | published by: BioSeeker Group AB
... 667 developmental projects in cancer. In addition, there are 3 suspended drugs and the accumulated number of ceased drugs over the last years amount to another 190 drugs. Proteins In Oncology Drug Pipeline Update lists ...  |  read more...
USD 6,746
Celera Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... Its products include ViroSeq HIV-1 genotyping system, cystic fibrosis, HLA products, chimerism, m2000 realtime system and reagents for laboratory developed tests, among others. Celera’s products helps to predict, diagnose, monitor and treat health problems. The ...  |  read more...
USD 750
Exosomics Siena SpA - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... models include contract research, collaborative projects, and technological services. Exosomics provides consultancy and technical services, such as sample preparation, sample analysis and characterization, and specific training. The company works in the domains of technological development ...  |  read more...
USD 750
Genomic Health, Inc. (GHDX) - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... consists of Oncotype DX breast cancer test,Oncotype DX colon cancer test, and Oncotype DX prostate cancer test. Its product pipeline helps optimize the treatment of urologic cancers including prostate, bladder and kidney cancers, as well ...  |  read more...
USD 750
GlycoZym - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... Glycozym provides services related to the PTM-peptide platform which includes ready-to-use PTM-peptide arrays, and custom build PTM-peptide libraries and arrays, as well as custom designed analysis. The company uses proprietary algorithms to design, synthesize, construct, ...  |  read more...
USD 750
IQuum, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... and flu A/B assay. IQuum’s Liat analyzer enables molecular diagnostic tests to be performed by healthcare workers, providing correct results immediately, and Liat Influenza A/B Assay is a lab based nucleic acid test. The company's ...  |  read more...
USD 750
Mycenax Biotech Inc. (4726) - Financial and Strategic SWOT Analysis Review
7/8/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Neogenix Oncology, Inc. - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for the detection of tumor without destroying healthy cells. NOI’s lead product candidate includes Ensituximab, recognizes a particular epitope of tumor specific antigens from pancreatic or colorectal adenocarcinoma. The company also has two additional preclinical ...  |  read more...
USD 750
Cleveland Biolabs, Inc. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Cleveland Biolabs, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports ...  |  read more...
USD 350
Ohmx Corporation - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... diagnosis and monitoring of patients with chronic diseases. The company’s products include biosensor chip, portable POC system and laboratory biosensor reader. Ohmx develops an automated disposable cartridge that will integrate microfluidic features for sample preparation. ...  |  read more...
USD 750
Oxford Biodynamics Limited - Product Pipeline Analysis, 2014 Update
7/15/2014 | published by: GlobalData
... for detection, monitoring and prognosis of major diseases associated with aberrant gene expression including oncology, inflammatory, metabolic, cardiovascular and neurodegenerative conditions. Oxford Bio’s products under clinical development include OBD 27, OBD 29, OBD 35, OBD ...  |  read more...
USD 750
Pharming Group N.V. (PHARM) - Financial and Strategic SWOT Analysis Review
7/22/2014 | published by: GlobalData
... you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand ...  |  read more...
USD 125
Compugen, Ltd. : Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report
7/15/2014 | published by: MarketLine
... and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Project Description: MarketLines' Compugen, Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers ...  |  read more...
USD 350
1    3    5  6  7  8  9  10